Clinical Trial Update: BeAT1D: Benign Autoimmunity and Type 1 Diabetes

View source ↗

Summary

BeAT1D is a trial investigating benign autoimmunity and Type 1 diabetes, sponsored by INSERM in France, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Type 1 Diabetes | Status: RECRUITING